跳至主要内容
临床试验/NCT05477121
NCT05477121已完成不适用

Severity: Quantifying the Severity of Generalized Tonic-clonic Seizures (GTCS) with Connected Devices

Centre Hospitalier Universitaire Vaudois1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2019年6月12日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
400
试验地点
1
主要终点
duration of PGES

研究概览

简要总结

By bringing together the fields of seizure detection and that of Sudden Unexpected Death in Epilepsy (SUDEP), the current project aims at delineating which set of biosensors and related biomarkers would optimally characterize the severity of GTCS and the associated risk of SUDEP.

详细描述

The main objective is to to evaluate which of the five biosignals considered, being, electrodermal activity (EDA), heart rate (HR), accelerometry (AC), arm-measurement of skin electromyography (EMG), and bed sensing of body movement (BM), or any of their combinations, offers the most accurate detection and quantification of our primary indicator of GTCS-severity, i.e. postictal EEG suppression (PGES).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
12 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female aged 12 years or older, suffering from epilepsy
  • Patient undergoing Video-EEG recording
  • Patient at risk of presenting a GTCS during Video-EEG monitoring according to one of the following criteria (i) known to suffer from GTCS, or (ii) considered for Antiepileptic drugs (AED) tapering during Video-EEG (GTCS often occur during Video-EEG as a result of AED tapering for promoting the occurrence of seizures).
  • Patient willing to participate in the study and signed informed consent, by patient or legal representative when required.

排除标准

  • Patients aged less than 12 years old
  • Patient not willing to participate in the study, and where informed consent from the patient or the legal representative, when required, cannot be obtained - Patient considered not at risk of presenting a GTCS during Video-EEG because they are not known to suffer GTCS and not candidate to AED tapering during Video-EEG.

结局指标

主要结局

duration of PGES

时间窗: Through study completion, an average of 4 years

The primary endpoint of the study is the duration of PGES, as defined by a postictal EEG flattening \<10microvolt over all scalp-EEG leads (time in seconds). When no PGES is observed, the duration will be coded as 0. This will be used as a dependent variable in the primary analysis.

次要结局

  • Type of GTCS(Through study completion, an average of 4 years)
  • GTCS tonic phase duration on video-EEG recording(Through study completion, an average of 4 years)
  • Postictal upper limb immobility duration on video-EEG recording(Through study completion, an average of 4 years)
  • Postictal bradycardia duration on EKG(Through study completion, an average of 4 years)
  • Postictal whole-body immobility duration on video-EEG recording(Through study completion, an average of 4 years)
  • Postictal bradycardia presence on Electrocardiogram (EKG)(Through study completion, an average of 4 years)
  • Postictal hypoxemia presence on pulse oxymetry(Through study completion, an average of 4 years)
  • Postictal hypoxemia duration on pulse oxymetry(Through study completion, an average of 4 years)
  • Postictal confusion duration on video-EEG recording(Through study completion, an average of 4 years)
  • Postictal hypoxemia nadir(Through study completion, an average of 4 years)
  • Peri-ictal tachycardia or bradycardia presence(Through study completion, an average of 4 years)
  • Peri-ictal tachycardia or bradycardia duration(Through study completion, an average of 4 years)
  • Abnormal heart-rate variability during the interictal period(Through study completion, an average of 4 years)
  • GTCS clonic phase duration on video-EEG recording(Through study completion, an average of 4 years)
  • Postictal bradycardia nadir on EKG(Through study completion, an average of 4 years)
  • Peri-ictal tachycardia or bradycardia intensity(Through study completion, an average of 4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Philippe Ryvlin

Professor, head of the department of clinical neurosciences, principal investigator

Centre Hospitalier Universitaire Vaudois

研究点 (1)

Loading locations...

相似试验